Drugs / Inhaled Carbon Monoxide
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02425579 | Apr 2015 → Aug 2019 | acute respiratory distress syndrome | Brigham and Women's Hospital | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01050712 | Apr 2011 → Sep 2013 | ileus | Queen's University | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inhaled Carbon Monoxide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01050712 ↗ |
| Route | Inhaled | “Patients randomized to received inhaled carbon monoxide will receive this concentration by cushioned face mask for one hour prior to colon resection and for one hour after...” NCT01050712 ↗ |